Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancerN. Iwai, Yoshito Itoh, Takashi Okuda et al.|Scientific Reports|2020Cited by 110
Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non–Small Cell Lung CancerYoshimasa Shiraishi, Isamu Okamoto, Junji Kishimoto et al.|JAMA Oncology|2023Cited by 52
Osimertinib versus osimertinib plus chemotherapy for non–small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trialKentaro Tanaka, Isamu Okamoto, Hajime Asahina et al.|European Journal of Cancer|2021Cited by 50
Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung CancerKoichi Takayama, Yoichi Nakanishi, Shunichi Sugawara et al.|Journal of Immunology Research|2016Cited by 25
Microbiological analysis of patients with first and recurrent episodes of acute cholangitis in a middle-sized hospital: A single-center retrospective study in rural North Kyoto, JapanTasuku Hara, Keizo Kagawa, Hiroaki Sakai et al.|Journal of Infection and Chemotherapy|2021Cited by 9